【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
• Drug profiles
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Clinical application
• Treatment guidelines
• Key buying criteria
PART 05: Hypercholesterolemia: An overview
• History of hypercholesterolemia
• Hypercholesterolemia management market dynamics
• Hypercholesterolemia prescription landscape
• Management of hypercholesterolemia
• Epidemiology
• Unmet medical needs and role of PCSK9 and CETP inhibitors
PART 06: Pipeline portfolio
• Information on pipeline candidates
PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 08: segmentation by type of disease
• FH
• Non-FH
PART 09: Market segmentation by MOA
• HMG-CoA reductase inhibitors
• Fibric acid derivatives
• Nicotinic acid
• Bile acid sequestrants
• Other
PART 10: Market segmentation by drug class
• Statins
• Non-statins
PART 11: Geographical segmentation
• Global hypercholesterolemia drugs market by geographical segmentation 2015-2020
• Hypercholesterolemia drugs market in Americas
• Hypercholesterolemia drugs market in EMEA
• Hypercholesterolemia drugs market in APAC
PART 12: Market drivers
• Increasing risk of CVDs
• Rising prevalence of chronic diseases
• Promising pipeline of drugs
• Change in ATP guidelines for management of hypercholesterolemia
• Growing older population
PART 13: Impact of drivers
PART 14: Market challenges
• Loss of patent exclusivity of branded therapies
• Drawbacks associated with current therapies
• High cost of therapy
• Stringent regulatory guidelines
• Lack of proper diagnosis
PART 15: Impact of drivers and challenges
PART 16: Market trends
• Expected entry of cost-effective OTC versions
• Increasing use of statins
• Increased use of combination therapies
• Consideration of lifestyle management in ATP guidelines
PART 17: Vendor landscape
• Competitive scenario
• Market share analysis 2015
PART 18: Key vendor analysis
• AbbVie
• Aegerion Pharmaceuticals
• AstraZeneca
• Merck
• Pfizer
• Sanofi
• Other prominent vendors
PART 19: Appendix
• List of abbreviations
PART 20: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Different class of lipoproteins
Exhibit 03: Evaluation of lipoprotein levels based on ATP III classification
Exhibit 04: Key buying criteria for hypercholesterolemia drugs
Exhibit 05: Timeline of cholesterol lowering drugs
Exhibit 06: Market dynamics for hypercholesterolemia
Exhibit 07: Prescription landscape for statins 2015
Exhibit 08: Prescription landscape for ezetimibe 2015
Exhibit 09: Prescription landscape for other classes 2015
Exhibit 10: Distribution of cholesterol-lowering medication for individuals above 40 years
Exhibit 11: Percentage use of prescription cholesterol-lowering medication in US for various indications 2015
Exhibit 12: Treatment of hypercholesterolemia
Exhibit 13: Pharmacological treatment of hypercholesterolemia
Exhibit 14: High cholesterol levels by race and ethnicity in US 2015
Exhibit 15: PCSK9 inhibitors in preclinical and clinical development 2015
Exhibit 16: Pipeline portfolio: Global hypercholesterolemia drugs market
Exhibit 17: Pipeline share of hypercholesterolemia drugs
Exhibit 18: Global hypercholesterolemia drugs market 2015-2020 ($ billions)
Exhibit 19: Five forces analysis
Exhibit 20: Classification of hyperlipidemia
Exhibit 21: Global hypercholesterolemia market segmentation by MOA
Exhibit 22: Global hypercholesterolemia market segmentation by MoA 2015
Exhibit 23: Global hypercholesterolemia drugs market segmentation by drug class
Exhibit 24: Global hypercholesterolemia drugs market by drug class 2015 (% share)
Exhibit 25: Hypercholesterolemia drugs market revenue by drug class 2015-2020 ($ billions)
Exhibit 26: Global statin market 2015-2020 ($ billions)
Exhibit 27: Number of prescriptions for statins in US
Exhibit 28: Usage of statins for hypercholesterolemia in US 2015
Exhibit 29: Usage of statins for hypercholesterolemia in UK 2015
Exhibit 30: Global non-statins market 2015-2020 ($ billions)
Exhibit 31: Number of prescriptions for non-statins in US
Exhibit 32: Global hypercholesterolemia drugs market: YoY growth and revenue based on drug class 2015-2020
Exhibit 33: Segmentation of global hypercholesterolemia drugs markets by geography 2015
Exhibit 34: Hypercholesterolemia drugs market revenue by geography 2015-2020 ($ billions)
Exhibit 35: Percentage share of hypercholesterolemia drugs market by geography 2015-2020 (%)
Exhibit 36: Hypercholesterolemia drugs market in Americas 2015-2020 ($ billions)
Exhibit 37: Share of hypercholesterolemia drugs market in Americas by country 2015
Exhibit 38: Hypercholesterolemia drugs market in EMEA 2015-2020 ($ billions)
Exhibit 39: Hypercholesterolemia drugs market in APAC 2015-2020 ($ billions)
Exhibit 40: Global hypercholesterolemia drugs market: YoY growth and revenue based on geography 2015-2020
Exhibit 41: Population aged 60 years and over: World, developed and developing regions ($ millions)
Exhibit 42: Impact of drivers
Exhibit 43: Impact of drivers and challenges
Exhibit 44: Arguments for and against OTC switch by pharmaceutical companies and regulatory organizations
Exhibit 45: Market share analysis of global hypercholesterolemia drugs market 2015
Exhibit 46: Revenue from the sales of top five products in hypercholesterolemia drugs market 2013-2015 ($ billions)
Exhibit 47: AbbVie: YoY revenue and growth rate of lipid franchise portfolio 2013-2015 ($ millions)
Exhibit 48: Key takeaways
Exhibit 49: Aegerion: YoY revenue and growth rate of JUXTAPID 2013-2015 ($ millions)
Exhibit 50: Key takeaways
Exhibit 51: AstraZeneca: YoY revenue and growth rate of Crestor 2013-2015 ($ billions)
Exhibit 52: AstraZeneca: Geographic segmentation of Crestor 2015 by revenue
Exhibit 53: Key takeaways
Exhibit 54: Merck: YoY revenue and growth rate of Zetia 2013-2015 ($ billions)
Exhibit 55: Merck: YoY revenue and growth rate of Vytorin 2013-2015 ($ billions)
Exhibit 56: Merck: YoY revenue and growth rate of Zocor 2013-2015 ($ millions)
Exhibit 57: Merck: Key takeaways
Exhibit 58: Pfizer: YoY revenue and growth rate of Lipitor 2013-2015 ($ billions)
Exhibit 59: Pfizer: Geographic segmentation of Lipitor by revenue 2015
Exhibit 60: Pfizer: YoY revenue and growth rate of Caduet 2012-2014 ($ millions)
Exhibit 61: Key takeaways
Exhibit 62: Sanofi: Key takeaways
【レポート販売概要】
■ タイトル：高コレステロール血症治療薬の世界市場2016-2020■ 英文：Global Hypercholesterolemia Drugs Market 2016-2020
■ 発行日：2016年7月25日
■ 調査会社：Technavio
■ 商品コード：IRTNTR9069
■ 調査対象地域：グローバル
- ステアリング装置の世界市場：EPS（電動パワーステアリング）、EHPS、HPS（油圧パワーステアリング）The steering system market size is projected to grow at a promising CAGR of 6.18% during the forecast period, to reach USD35.99 Billion by 2020. The recent increase in demand for automobiles in the U.S. and Mexico has confirmed that the North American automotive industry has begun its recovery phase and according to industry experts, the market is projected to continue with a similar growth trend …
- カジノゲームの世界市場2017-2021About Casino Gaming A casino is more of a tourist attraction and indoor amusement zone. It offers services in hotels, restaurants, and shopping malls. The majority of the revenue comes from gambling. Casinos are concentrated in certain regions because gambling is illegal in several parts of the world. However, a large number of countries are easing regulations to support the growth of casinos beca …
- 欧州の風力発電産業分析：Analyzing the European Wind Power IndustryAs demand on finite petroleum reserves and the price of the fuels derived from them continues to rise, renewable forms of energy are becoming more cost-effective and profitable. In the forefront of this renewable revolution is harnessing the sustainable power of wind. Today it is one of the most positive developments created by the present storm of uncertainty unleashed as a result of escalating o …
- 世界のコバルト市場動向（2014-2018）TechNavio's analysts forecast the Global Cobalt market to grow at a CAGR of 6.05 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased demand for cobalt from the Battery Chemicals industry. The Global Cobalt market has also been witnessing the supply constraints of cobalt leading to high prices. However, the cobalt supply challenges could pos …
- M2M事業戦略と計画（M2M Business Strategy and Planning）We are in the early stages of a new era of the Internet. A big part of this new era will involve the so called "Internet of Things" in which various objects (equipment, machines, electronics, vehicles, appliances, and other assets) communicate with one another and to remote servers via Machine-to-Machine (M2M). However, the M2M market is extremely fragmented and difficult to analyze since most M2M …
- ヘキサフルオロアセトンの世界市場Hexafluoroacetone (CAS 684-16-2) Market Research Report 2013 presents comprehensive data on hexafluoroacetone markets globally and regionally (Europe, Asia, North America etc.) The Hexafluoroacetone (CAS 684-16-2) Market Research Report 2013 includes hexafluoroacetone description, covers its application areas and related patterns. It overviews hexafluoroacetone market, names hexafluoroacetone prod …
- 麻酔気化器の世界市場2016-2020About Anesthesia Delivery System An anesthesia delivery system, which includes anesthesia machine and a breathing circuit, supports in pain management just before the surgical (pre-surgical) procedure. The anesthesia machine includes an anesthesia vaporizer, where the vaporizer mixes both anesthetic agent and oxygen together and delivers to the individual during the pre-surgical procedure through …
- 世界のメーターデータ管理（MDM）市場動向（2012-2016）TechNavio's analysts forecast the Global Meter Data Management market to grow at a CAGR of 16.55 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need to reduce the incidences of electricity theft. The Global Meter Data Management market has also been witnessing an increasing support from regulatory authorities. However, data management issues cou …
- 塩素酸ナトリウムの世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world sodium chlorate market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true i …
- 世界のPTCAバルーンカテーテル市場動向（2012-2016）TechNavio's analysts forecast the Global PTCA Balloon Catheter market to grow at a CAGR of 8.24 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of CVD. The Global PTCA Balloon Catheter market has also been witnessing an increase in demand for minimally invasive procedures. However, the availability of alternative procedures …
- 2014 World Animal Health Market Outlook and Leading Supplier Business Strategies and Marketing TacticsThis new 80-page report from Venture Planning Group analyzes business strategies and marketing tactics of the world’s leading animal health companies, including: Five-year forecasts for: - Major market segments - Key geographic regionsAssessment of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, inclu …
- 脂肪性肝疾患(Fatty Liver Disease)：治療薬開発パイプライン動向（2015年上半期版）Fatty Liver Disease - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Fatty Liver Disease - Pipeline Review, H1 2015’, provides an overview of the Fatty Liver Disease’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Fatty Liver Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, m …
- 金属代替材料の世界市場予測：エンジニアリング・プラスチック、複合材料The metal replacement market is projected to reach USD 159.82 Billion by 2021, at a CAGR of 9.2% from 2016 to 2021. The key factor propelling the growth of the metal replacement market is the increasing demand for metal replacing materials from the automotive and aerospace & defense industries. Major end-use industries in the metal replacement market include automotive, aerospace & defense, constr …
- 世界における核酸検査機器市場及び主要サプライヤー動向This 103-page report is designed to help suppliers identify and evaluate emerging opportunities for further automating NAT methods in order to facilitate their penetration into the routine clinical laboratory market. Some instrumentation is already available on the market, e.g., DNA extractors, DNA synthesizers, thermal cyclers, robotic work-stations, and automated DNA probe analysis systems …
- 希土類金属の世界市場2017-2021ABSTRACTAbout Rare Earth Metals Rare earth metals comprise 17 chemical elements in the periodic table, which include fifteen elements of the lanthanide series, and scandium and yttrium. Scandium and yttrium are also considered rare earth metals as they are found in the same mineral ore deposits as the other elements of the lanthanide series. Rare earth metals have unique physical and chemical prop …
